Search results
French, US drug firms team up for Covid-flu shot
AFP via Yahoo Finance· 13 hours agoFrench pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines...
Novavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall By Investing.com
Investing.com· 11 hours agoNovavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall
Planet Fitness Price Increase: Goodbye $10 Membership Plans
InvestorPlace· 6 hours agoA Planet Fitness (NYSE:PLNT) price increase will result in some members having to pay more if they...
The Sanofi-Novavax vaccine deal is worth up to $1.2 billion
The Port Lavaca Wave· 9 hours agoThe Sanofi-Novavax vaccine deal is worth up to $1.2 billion
Trending tickers: TSMC, Novavax, Anglo American and IAG
Yahoo Finance UK· 14 hours ago"We are entering an AI-empowered world, where artificial intelligence not only runs in data centres,...
Novavax: Q1 Earnings Snapshot
San Francisco Chronicle· 14 hours agoGAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Friday reported a loss of $147.6 million in its first quarter. On a per-share basis, the Gaithersburg, Maryland-based company ...
UPDATE 3-Novavax signs COVID-19 license deal with Sanofi, revokes 'going concern' warning
Reuters via Yahoo Finance· 17 hours agoNovavax on Friday removed doubts about its ability to remain in business and struck a licensing deal worth up to $1.2 billion with Sanofi for COVID-19 vaccines in exchange ...
Novavax: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 14 hours agoGAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Friday reported a loss of $147.6 million in its first quarter. On a per-share basis, the Gaithersburg ...
Midday movers: Novavax, Nvidia, Sweetgreen rise; Moderna, Yelp fall By Investing.com
Investing.com· 11 hours agoMidday movers: Novavax, Nvidia, Sweetgreen rise; Moderna, Yelp fall
Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi
Morningstar· 12 hours agoShares of Novavax surged after the company disclosed a $1.4 billion licensing deal with Sanofi. The stock was up 72% at $7.66 in premarket trading on Friday. The vaccine maker ...
